World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $114.89bn | 28.88 | n/a |
REGNRegeneron Pharmaceuticals | $108.23bn | 28.01 | n/a |
MRNAModerna | $50.93bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $42.12bn | 30.02 | n/a |
LONNLonza AG | CH₣38.16bn | 36.75 | 0.76% |
068270Celltrion | KR₩39tn | 70.34 | 0.26% |
ICLRIcon | $26.02bn | 34.8 | n/a |
ARGXargenx SE | €20.20bn | n/a | n/a |
BNTXBioNTech SE | $21.54bn | 166.05 | n/a |
GMABGenmab A/S | DKK132.97bn | 24.65 | n/a |
ALNYAlnylam Pharmaceuticals | $18.90bn | n/a | n/a |
NBIXNeurocrine Biosciences | $14.32bn | 38.7 | n/a |
TECHBIO-TECHNE | $13.21bn | 62.39 | 0.38% |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
SRPTSarepta Therapeutics | $12.42bn | n/a | n/a |
MEDPMedpace Holdings | $12.19bn | 40.08 | n/a |
UTHRUnited Therapeutics | $12.16bn | 12.95 | n/a |
CRLCharles River Laboratories International | $11.42bn | 23.73 | n/a |
QGENQiagen NV | $10.14bn | 27.43 | n/a |